James M Mock $MRNA SEC Form 4 Insider Trading

James M Mock has filed a total of 14 insider trades in $MRNA since 2021. Their most recent trade was a sale of 15,000 shares, made on Sep 10, 2026. Their largest trade was a sale of 19,836 shares, made on Sep 10, 2026. We estimate that they now own 80,079 shares of $MRNA, worth an estimated $11.0 million.

Insider Trading at $MRNA

There have been a total of 1454 insider trades reported at $MRNA since 2021, with 191,934 shares purchased and 9.7 million shares sold. The most active insider traders in $MRNA stock have been Stephane Bancel, Stephen Hoge, and Juan Andres. The most recent trade was a sale of 15,000 shares reported by James M Mock (Chief Financial Officer), made on Sep 10, 2026.

$MRNA Executives and Stock Owners with Insider Trades

• Stephane Bancel, Chief Executive Officer

• Stephen Hoge, President

• Juan Andres, See remarks

• Shannon Thyme Klinger, Chief Legal Officer

• James M Mock, Chief Financial Officer

• Tal Zvi Zaks, Chief Medical Officer

• Arpa Garay, Chief Commercial Officer

• David W Meline, Chief Financial Officer

• Paul Burton, Chief Medical Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.